A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets

NCT01100320 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Purdue Pharma LP